Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J's Invokana continues downward market-share spiral as Lilly, BI's Jardiance advances
J&J's Invokana continues downward market-share spiral as Lilly, BI's Jardiance advances
J&J's Invokana continues downward market-share spiral as Lilly, BI's Jardiance advances
Submitted by
admin
on July 19, 2017 - 7:47pm
Source:
Fierce Pharma
News Tags:
JNJ
Invokana
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
Headline:
J&J's Invokana continues downward market-share spiral as Lilly, BI's Jardiance advances
Do Not Allow Advertisers to Use My Personal information
